Model
Edge
CRISPR Therapeutics
0001968317
Filing Type
4
Filing Date
3/17/2025
Updated
3/18/25, 3:35 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership